stars 1 stars 2 stars 3

Cell Reprogramming & Therapeutics LLC is focused on the development and commercialization of cell-based technologies to target diseases of the central nervous system. The company’s programs aim to develop cellular models and therapeutics for neurological disorders such as Brain and Spinal cord injuries, Stroke, Parkinson's, Alzheimer's, Amyotrophic Lateral Sclerosis, Huntington's and brain cancers.

Cell Reprogramming & Therapeutics LLC Questions

The Cell Reprogramming & Therapeutics LLC annual revenue was $400000 in 2026.

Arshak Alexanian is the Chief Scientific Officer of Cell Reprogramming & Therapeutics LLC.

3 people are employed at Cell Reprogramming & Therapeutics LLC.

Cell Reprogramming & Therapeutics LLC is based in Wauwatosa, Wisconsin.

The NAICS codes for Cell Reprogramming & Therapeutics LLC are [541714, 54171, 541, 54, 5417].

The SIC codes for Cell Reprogramming & Therapeutics LLC are [87, 873].

Top Cell Reprogramming & Therapeutics LLC Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users